Cash flow Moderna, Inc.

Equities

MRNA

US60770K1079

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 04:00:00 2025-12-12 pm EST			5-day change	1st Jan Change
29.46 ^USD	-0.57%		+6.35%	-29.15%

Dec. 12	Morgan Stanley Adjusts Moderna Price Target to $28 From $30, Maintains Equalweight Rating	MT
Dec. 12	Rate Cuts Can't Buy Confidence

e1bfb3a5f14e12393d7dc69.VndpQ4BVcwlYfFqO1zv2AsdO87ILimnmyFCKHnkYhJw.F0YGbtY0NFxqHSzqu1isd4Iam_9e-iulgDm-QSwv08YUMy0x2gEkPxYTEw

Published financial data: MODERNA, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	803M	18.47B	19.26B	6.67B	3.11B
Other Revenues, Total	-	-	-	177M	127M
Total Revenues	803M	18.47B	19.26B	6.85B	3.24B
Cost of Goods Sold, Total	1.38B	4.61B	8.71B	9.54B	6.01B
Gross Profit	-575M	13.86B	10.55B	-2.69B	-2.77B
Selling General & Admin Expenses, Total	188M	567M	1.13B	1.55B	1.17B
Other Operating Expenses, Total	188M	567M	1.13B	1.55B	1.17B
Operating Income	-763M	13.3B	9.42B	-4.24B	-3.94B
Interest Expense, Total	-9.89M	-18M	-29M	-38M	-24M
Interest And Investment Income	24.72M	18M	200M	421M	425M
Net Interest Expenses	14.83M	0	171M	383M	401M
Currency Exchange Gains (Loss)	-	-8M	48M	-	-
Other Non Operating Income (Expenses)	2.74M	-4M	-44M	-14M	-7M
EBT, Excl. Unusual Items	-746M	13.28B	9.6B	-3.87B	-3.55B
Gain (Loss) On Sale Of Investments	1.3M	1M	-20M	-72M	-56M
Gain (Loss) On Sale Of Assets	-238K	-	-	-	-
EBT, Incl. Unusual Items	-745M	13.28B	9.58B	-3.94B	-3.61B
Income Tax Expense	2.55M	1.08B	1.21B	772M	-46M
Earnings From Continuing Operations	-747M	12.2B	8.36B	-4.71B	-3.56B
Net Income to Company	-747M	12.2B	8.36B	-4.71B	-3.56B
Net Income - (IS)	-747M	12.2B	8.36B	-4.71B	-3.56B
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	-747M	12.2B	8.36B	-4.71B	-3.56B
Net Income to Common Excl. Extra Items	-747M	12.2B	8.36B	-4.71B	-3.56B
Per Share Items
Net EPS - Basic	-1.96	30.28	21.22	-12.34	-9.27
Basic EPS - Continuing Operations	-1.96	30.28	21.22	-12.34	-9.27
Basic Weighted Average Shares Outstanding	381M	403M	394M	382M	384M
Net EPS - Diluted	-1.96	28.29	20.12	-12.34	-9.28
Diluted EPS - Continuing Operations	-1.96	28.29	20.12	-12.34	-9.28
Diluted Weighted Average Shares Outstanding	381M	431M	416M	382M	384M
Normalized Basic EPS	-1.22	20.6	15.22	-6.33	-5.78
Normalized Diluted EPS	-1.22	19.26	14.42	-6.33	-5.78
Payout Ratio	-	-	-	-	-
American Depositary Receipts Ratio (ADR)	0.1	0.1	0.1	0.1	0.1
Supplemental Items
EBITDA	-732M	13.53B	9.77B	-3.62B	-3.76B
EBITA	-763M	13.3B	9.42B	-4.24B	-3.94B
EBIT	-763M	13.3B	9.42B	-4.24B	-3.94B
EBITDAR	-696M	13.7B	9.98B	-3.42B	-3.6B
Total Revenues (As Reported)	803M	18.47B	19.26B	6.85B	3.24B
Effective Tax Rate - (Ratio)	-0.34	8.15	12.67	-19.58	1.28
Current Domestic Taxes	32K	1.34B	1.73B	-153M	-58M
Current Foreign Taxes	2.52M	40M	57M	24M	13M
Total Current Taxes	2.55M	1.38B	1.79B	-129M	-45M
Deferred Domestic Taxes	-	-294M	-576M	896M	-
Deferred Foreign Taxes	-	-2M	-2M	5M	-1M
Total Deferred Taxes	-	-296M	-578M	901M	-1M
Normalized Net Income	-466M	8.3B	6B	-2.42B	-2.22B
Interest on Long-Term Debt	9.89M	17M	29M	38M	24M
Supplemental Operating Expense Items
Advertising Expense	-	-	-	204M	146M
Selling and Marketing Expenses	-	-	-	204M	146M
General and Administrative Expenses	-	-	-	-	-
Research And Development Expense From Footnotes	1.37B	1.99B	3.3B	4.84B	4.54B
Net Rental Expense, Total	35.49M	173M	213M	203M	158M
Imputed Operating Lease Interest Expense	15.03M	43.21M	46.71M	50.52M	30.49M
Imputed Operating Lease Depreciation	20.46M	130M	166M	152M	128M
Stock-Based Comp., COGS (Total)	56.16M	90M	138M	194M	289M
Stock-Based Comp., G&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	36.87M	52M	88M	111M	140M
Total Stock-Based Compensation	93.02M	142M	226M	305M	429M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	2.62B	6.85B	3.2B	2.91B	1.93B
Short Term Investments	1.98B	3.88B	6.7B	5.7B	5.1B
Total Cash And Short Term Investments	4.61B	10.73B	9.9B	8.6B	7.02B
Accounts Receivable, Total	1.39B	3.18B	1.38B	892M	358M
Other Receivables	19.97M	121M	243M	189M	234M
Notes Receivable	-	-	36M	-	-
Total Receivables	1.41B	3.3B	1.66B	1.08B	592M
Inventory	46.53M	1.44B	1.17B	270M	117M
Prepaid Expenses	15.65M	126M	216M	266M	173M
Restricted Cash	1.03M	-	-	-	-
Other Current Assets, Total	217M	481M	481M	104M	192M
Total Current Assets	6.3B	16.07B	13.43B	10.32B	8.1B
Gross Property Plant And Equipment	507M	1.74B	2.8B	3.09B	3.48B
Accumulated Depreciation	-120M	-352M	-658M	-433M	-527M
Net Property Plant And Equipment	387M	1.38B	2.14B	2.66B	2.96B
Long-term Investments	639M	6.84B	8.36B	4.74B	2.51B
Goodwill	-	-	-	52M	52M
Other Intangibles, Total	-	-	-	44M	40M
Deferred Tax Assets Long-Term	-	326M	982M	81M	-
Other Long-Term Assets, Total	12.93M	46M	946M	523M	488M
Total Assets	7.34B	24.67B	25.86B	18.43B	14.14B
Liabilities
Accounts Payable, Total	18.36M	302M	487M	520M	405M
Accrued Expenses, Total	452M	1.47B	1.83B	1.07B	898M
Current Portion of Leases	30.3M	211M	196M	25M	37M
Current Income Taxes Payable	-	876M	48M	63M	-
Unearned Revenue Current, Total	3.87B	6.25B	2.04B	568M	153M
Other Current Liabilities	20.94M	14M	321M	770M	713M
Total Current Liabilities	4.39B	9.13B	4.92B	3.02B	2.21B
Long-Term Debt	-	-	-	-	-
Long-Term Leases	207M	705M	1B	1.22B	710M
Unearned Revenue Non Current	177M	615M	673M	83M	58M
Other Non Current Liabilities	1.85M	76M	135M	256M	267M
Total Liabilities	4.78B	10.52B	6.74B	4.57B	3.24B
Preferred Stock Convertible	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	40K	-	-	-	-
Additional Paid In Capital	4.8B	4.21B	1.17B	371M	866M
Retained Earnings	-2.24B	9.96B	18.32B	13.61B	10.04B
Comprehensive Income and Other	3M	-24M	-370M	-123M	-10M
Total Common Equity	2.56B	14.14B	19.12B	13.85B	10.9B
Total Equity	2.56B	14.14B	19.12B	13.85B	10.9B
Total Liabilities And Equity	7.34B	24.67B	25.86B	18.43B	14.14B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	400M	403M	386M	382M	386M
ECS Total Common Shares Outstanding	399M	403M	385M	382M	386M
Book Value / Share	6.42	35.1	49.67	36.27	28.24
Tangible Book Value	2.56B	14.14B	19.12B	13.76B	10.81B
Tangible Book Value Per Share	6.42	35.1	49.67	36.02	28
Total Debt	238M	916M	1.2B	1.24B	747M
Net Debt	-4.37B	-16.65B	-17.02B	-12.04B	-8.77B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-	9M	8M	-	-
Debt Equivalent Oper. Leases	284M	1.38B	1.7B	1.62B	1.26B
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	36.22M	870M	575M	163M	63M
Inventories - Work In Process, Total	9.02M	338M	205M	15M	26M
Inventories - Finished Goods, Total	1.29M	233M	169M	24M	28M
Land - (BS)	-	-	11M	22M	59M
Buildings, Total	-	-	-	-	743M
Machinery, Total	139M	202M	343M	445M	525M
Full Time Employees	1.3K	2.7K	3.9K	5.6K	5.8K
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	340M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-747M	12.2B	8.36B	-4.71B	-3.56B
Depreciation & Amortization - CF	93.54M	232M	348M	621M	189M
Depreciation & Amortization, Total	93.54M	232M	348M	621M	189M
(Gain) Loss From Sale Of Asset	238K	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	10.18M	54M	31M	-26M	-43M
Stock-Based Compensation (CF)	93.02M	142M	226M	305M	429M
Other Operating Activities, Total	-	-318M	-531M	835M	60M
Change In Accounts Receivable	-1.39B	-1.78B	1.79B	493M	534M
Change In Inventories	-46.53M	-1.39B	492M	747M	83M
Change In Accounts Payable	11.88M	204M	240M	13M	-69M
Change in Unearned Revenues	3.84B	2.82B	-4.16B	-2.06B	-439M
Change In Income Taxes	-	876M	-828M	15M	-
Change In Deferred Taxes	-	-	-	-	-
Change in Other Net Operating Assets	155M	582M	-992M	653M	-187M
Cash from Operations	2.03B	13.62B	4.98B	-3.12B	-3B
Capital Expenditure	-67.45M	-284M	-400M	-707M	-1.05B
Cash Acquisitions	-	-	-	-85M	-
Investment in Marketable and Equity Securities, Total	-1.6B	-8.24B	-4.74B	5.02B	3B
Other Investing Activities, Total	-	-	-40M	-23M	-
Cash from Investing	-1.67B	-8.52B	-5.18B	4.21B	1.95B
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Long-Term Debt Repaid, Total	-6.22M	-140M	-184M	-270M	-10M
Total Debt Repaid	-6.22M	-140M	-184M	-270M	-10M
Issuance of Common Stock	2.04B	124M	65M	46M	66M
Repurchase of Common Stock	-	-857M	-3.33B	-1.15B	-
Issuance of Preferred Stock	-	-	-	-	-
Repurchase of Preferred Stock	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Cash from Financing	2.03B	-873M	-3.45B	-1.38B	56M
Net Change in Cash	2.39B	4.22B	-3.64B	-289M	-999M
Supplemental Items
Cash Interest Paid	8.53M	14M	25M	39M	24M
Cash Income Tax Paid (Refund)	572K	480M	2.73B	-357M	197M
Levered Free Cash Flow	2.19B	9.29B	3.67B	-2.38B	-3.09B
Unlevered Free Cash Flow	2.2B	9.3B	3.69B	-2.36B	-3.07B
Change In Net Working Capital	-2.55B	-904M	2.38B	-71M	174M
Net Debt Issued / Repaid	-6.22M	-140M	-184M	-270M	-10M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-10.69	51.93	23.3	-11.97	-15.14
Return on Total Capital	-23.21	93.06	33.28	-14.96	-18.44
Return On Equity %	-39.99	146.08	50.27	-28.59	-28.77
Return on Common Equity	-39.99	146.08	50.27	-28.59	-28.77
Margin Analysis
Gross Profit Margin %	-71.56	75.05	54.78	-39.28	-85.63
SG&A Margin	23.43	3.07	5.88	22.62	36.28
EBITDA Margin %	-91.1	73.24	50.71	-52.83	-116.07
EBITA Margin %	-94.99	71.98	48.9	-61.9	-121.91
EBIT Margin %	-94.99	71.98	48.9	-61.9	-121.91
Income From Continuing Operations Margin %	-92.99	66.06	43.41	-68.84	-110.04
Net Income Margin %	-92.99	66.06	43.41	-68.84	-110.04
Net Avail. For Common Margin %	-92.99	66.06	43.41	-68.84	-110.04
Normalized Net Income Margin	-58	44.95	31.13	-35.32	-68.58
Levered Free Cash Flow Margin	272.65	50.31	19.04	-34.8	-95.41
Unlevered Free Cash Flow Margin	273.42	50.37	19.14	-34.45	-94.95
Asset Turnover
Asset Turnover	0.18	1.15	0.76	0.31	0.2
Fixed Assets Turnover	2.38	20.87	10.94	2.86	1.15
Receivables Turnover (Average Receivables)	1.15	8.09	8.45	5.86	4.97
Inventory Turnover (Average Inventory)	-	6.19	6.02	13.27	37.66
Short Term Liquidity
Current Ratio	1.43	1.76	2.73	3.42	3.67
Quick Ratio	1.37	1.54	2.34	3.21	3.45
Operating Cash Flow to Current Liabilities	0.46	1.49	1.01	-1.03	-1.36
Days Sales Outstanding (Average Receivables)	317.97	45.11	43.2	62.29	73.58
Days Outstanding Inventory (Average Inventory)	-	58.93	60.67	27.51	9.72
Average Days Payable Outstanding	-	9.73	17.67	21.27	28.58
Cash Conversion Cycle (Average Days)	-	94.32	86.21	68.54	54.71
Long Term Solvency
Total Debt/Equity	9.28	6.48	6.28	8.97	6.85
Total Debt / Total Capital	8.49	6.08	5.9	8.23	6.41
LT Debt/Equity	8.09	4.98	5.25	8.79	6.51
Long-Term Debt / Total Capital	7.41	4.68	4.94	8.07	6.1
Total Liabilities / Total Assets	65.09	42.66	26.05	24.81	22.92
EBIT / Interest Expense	-77.19	738.67	324.83	-111.55	-164.38
EBITDA / Interest Expense	-70.44	761.17	344.17	-89.87	-149.92
(EBITDA - Capex) / Interest Expense	-77.27	745.39	330.38	-108.47	-193.71
Total Debt / EBITDA	-0.34	0.07	0.12	-0.36	-0.21
Net Debt / EBITDA	6.28	-1.22	-1.71	3.53	2.44
Total Debt / (EBITDA - Capex)	-0.31	0.07	0.13	-0.3	-0.16
Net Debt / (EBITDA - Capex)	5.72	-1.24	-1.78	2.92	1.89
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	1.23K	2.2K	4.29	-64.45	-52.75
Gross Profit, 1 Yr. Growth %	31.82	-2.51K	-23.88	-125.49	3.01
EBITDA, 1 Yr. Growth %	42.2	-1.95K	-27.79	-137.04	3.81
EBITA, 1 Yr. Growth %	39.84	-1.84K	-29.15	-145	-6.94
EBIT, 1 Yr. Growth %	39.84	-1.84K	-29.15	-145	-6.94
Earnings From Cont. Operations, 1 Yr. Growth %	45.34	-1.73K	-31.47	-156.37	-24.46
Net Income, 1 Yr. Growth %	45.34	-1.73K	-31.47	-156.37	-24.46
Normalized Net Income, 1 Yr. Growth %	44.85	-1.88K	-27.77	-140.33	-8.24
Diluted EPS Before Extra, 1 Yr. Growth %	26.08	-1.54K	-28.88	-161.33	-24.8
Accounts Receivable, 1 Yr. Growth %	25.8K	128.25	-56.38	-35.6	-59.87
Inventory, 1 Yr. Growth %	-	2.97K	-32.41	-76.88	-42.08
Net Property, Plant and Equip., 1 Yr. Growth %	34.45	257.36	54.66	24.26	11.17
Total Assets, 1 Yr. Growth %	361.6	236.23	4.82	-28.74	-23.25
Tangible Book Value, 1 Yr. Growth %	118.02	452.32	35.19	-28.06	-21.43
Common Equity, 1 Yr. Growth %	118.02	452.32	35.19	-27.55	-21.32
Cash From Operations, 1 Yr. Growth %	-541.64	571.93	-63.43	-162.6	-3.66
Capital Expenditures, 1 Yr. Growth %	113.75	317.65	40.84	76.75	48.66
Levered Free Cash Flow, 1 Yr. Growth %	-759.55	324.3	-60.53	-164.95	29.56
Unlevered Free Cash Flow, 1 Yr. Growth %	-769.75	323.6	-60.38	-163.98	30.23
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	143.89	1.65K	389.78	-39.11	-59.01
Gross Profit, 2 Yr. CAGR %	34.24	463.88	328.38	-55.95	-48.76
EBITDA, 2 Yr. CAGR %	37.27	412.52	265.3	-48.28	-37.99
EBITA, 2 Yr. CAGR %	35.89	393.47	251.37	-43.54	-35.29
EBIT, 2 Yr. CAGR %	35.89	393.47	251.37	-43.54	-35.29
Earnings From Cont. Operations, 2 Yr. CAGR %	39.35	387.23	234.58	-37.84	-34.74
Net Income, 2 Yr. CAGR %	39.35	387.23	234.58	-37.84	-34.74
Normalized Net Income, 2 Yr. CAGR %	38.17	407.88	259.12	-46.03	-39.1
Diluted EPS Before Extra, 2 Yr. CAGR %	-37.12	326.82	220.34	-33.95	-32.09
Accounts Receivable, 2 Yr. CAGR %	951.16	2.33K	-0.22	-47	-49.16
Inventory, 2 Yr. CAGR %	-	-	398.51	-60.47	-68.35
Net Property, Plant and Equip., 2 Yr. CAGR %	35.13	119.17	135.1	38.63	17.54
Total Assets, 2 Yr. CAGR %	93.37	293.96	87.73	-13.57	-26.05
Tangible Book Value, 2 Yr. CAGR %	29.38	246.99	173.26	-1.38	-24.82
Common Equity, 2 Yr. CAGR %	29.38	246.99	173.26	-1.03	-24.5
Cash From Operations, 2 Yr. CAGR %	147.51	444.73	56.76	-52.15	-22.34
Capital Expenditures, 2 Yr. CAGR %	-20.14	197.91	142.54	57.78	62.1
Levered Free Cash Flow, 2 Yr. CAGR %	195.06	431.67	29.42	-49.36	-8.26
Unlevered Free Cash Flow, 2 Yr. CAGR %	196.62	431.99	29.55	-49.64	-8.7
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	57.45	415.2	584.74	104.31	-44.04
Gross Profit, 3 Yr. CAGR %	41.1	251.57	189.26	67.25	-41.53
EBITDA, 3 Yr. CAGR %	43.28	226.58	166.69	70.34	-34.76
EBITA, 3 Yr. CAGR %	41.5	218.05	158.4	77.11	-33.3
EBIT, 3 Yr. CAGR %	41.5	218.05	158.4	77.11	-33.3
Earnings From Cont. Operations, 3 Yr. CAGR %	42.92	216.54	153.39	84.79	-33.67
Net Income, 3 Yr. CAGR %	42.92	216.54	153.39	84.79	-33.67
Normalized Net Income, 3 Yr. CAGR %	43.01	224	165.1	73.27	-35.58
Diluted EPS Before Extra, 3 Yr. CAGR %	-22.35	78.74	134.87	84.63	-31.03
Accounts Receivable, 3 Yr. CAGR %	369.73	531.87	536.58	-13.77	-51.69
Inventory, 3 Yr. CAGR %	-	-	-	79.1	-59.24
Net Property, Plant and Equip., 3 Yr. CAGR %	40.68	86.86	95.13	90.09	28.8
Total Assets, 3 Yr. CAGR %	89.13	132.53	153.39	35.93	-16.93
Tangible Book Value, 3 Yr. CAGR %	66.86	109.87	153.43	75.14	-8.58
Common Equity, 3 Yr. CAGR %	66.86	109.87	153.43	75.54	-8.32
Cash From Operations, 3 Yr. CAGR %	82.86	245.28	121.4	15.44	-39.58
Capital Expenditures, 3 Yr. CAGR %	4.92	38.99	132.08	118.26	54.68
Levered Free Cash Flow, 3 Yr. CAGR %	152.69	233.02	123.46	2.85	-30.74
Unlevered Free Cash Flow, 3 Yr. CAGR %	152.98	234.01	123.83	2.41	-30.88
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	179.44	147.88	119.28	122.01
Gross Profit, 5 Yr. CAGR %	-	142.2	120.02	53.18	44.75
EBITDA, 5 Yr. CAGR %	-	130.34	108.35	56.26	48.79
EBITA, 5 Yr. CAGR %	-	126.35	103.58	59.3	48.52
EBIT, 5 Yr. CAGR %	-	126.35	103.58	59.3	48.52
Earnings From Cont. Operations, 5 Yr. CAGR %	-	124.03	100.84	65.06	47.27
Net Income, 5 Yr. CAGR %	-	124.03	100.84	65.06	47.27
Normalized Net Income, 5 Yr. CAGR %	-	128.6	106.6	58.2	47.13
Diluted EPS Before Extra, 5 Yr. CAGR %	-	49.47	36.9	20.02	42.98
Accounts Receivable, 5 Yr. CAGR %	-	197.94	152.79	134.48	131.63
Net Property, Plant and Equip., 5 Yr. CAGR %	-	76.3	72.75	65.83	59.32
Total Assets, 5 Yr. CAGR %	-	77.07	88.57	56.51	54.83
Tangible Book Value, 5 Yr. CAGR %	-	111.43	103.25	55.15	55.87
Common Equity, 5 Yr. CAGR %	-	111.43	103.25	55.37	56.13
Cash From Operations, 5 Yr. CAGR %	-	189.71	71.94	56.62	45.61
Capital Expenditures, 5 Yr. CAGR %	-	53.67	46.94	46.22	101.04
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	93.35	56.78	56.51
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	93.56	56.71	56.36